[1]
|
Lopez-Beltran, A., Scarpelli, M., Rodolfo, M., et al. (2006) 2004 WHO Classification of the Renal Tumors of the Adults. European Urology, 49, 798-805. https://doi.org/10.1016/j.eururo.2005.11.035
|
[2]
|
Calio, A., Segala, D., Munari, E., et al. (2019) MiT Family Translocation Renal Cell Carcinoma: From the Early Descriptions to the Current Knowledge. Cancers (Basel), 11, Article No. 1110. https://doi.org/10.3390/cancers11081110
|
[3]
|
Al-Maghrabi, J.A. and Khabaz, M.N. (2020) Uncommon Localization of Extrarenal Xp11.2 Translocation-Associated Renal Cell Carcinoma (RCC): Case Report. Applied Immunohistochemistry & Molecular Morphology, 28, E33-E35.
https://doi.org/10.1097/PAI.0000000000000576
|
[4]
|
Tomlinson, G.E., Nisen, P.D., Timmons, C.F., et al. (1991) Cytogenetics of a Renal-Cell Carcinoma in a 17-Month-Old Child—Evidence for XP11.2 as a Recurring Breakpoint. Cancer Genetics and Cytogenetics, 57, 11-17.
https://doi.org/10.1016/0165-4608(91)90184-V
|
[5]
|
Muller-Hocker, J., Babaryka, G., Schmid, I., et al. (2008) Overexpression of Cyclin D1, D3, and p21 in an Infantile Renal Carcinoma with Xp11.2 TFE3-Gene Fusion. Pathology Research and Practice, 204, 589-597.
https://doi.org/10.1016/j.prp.2008.01.010
|
[6]
|
Argani, P., Lae, M., Ballard, E.T., et al. (2006) Translocation Car-cinomas of the Kidney after Chemotherapy in Childhood. Journal of Clinical Oncology, 24, 1529-1534. https://doi.org/10.1200/JCO.2005.04.4693
|
[7]
|
Cimadamore, A., Cheng, L., Scarpelli, M., et al. (2021) Towards a New WHO Classification of Renal Cell Tumor: What the Clinician Needs to Know—A Narrative Review. Translational Andrology and Urology, 10, 1506-1520.
https://doi.org/10.21037/tau-20-1150
|
[8]
|
朱庆强, 王中秋, 吴晶涛, 等. XP11.2易位TFE基因融合相关性肾癌的多层螺旋CT表现[J]. 中华放射学杂志, 2012, 46(6): 516-520.
|
[9]
|
陶磊, 崔文静, 刘丽, 等. Xp11.2易位/TFE3基因融合相关性肾癌影像表现及病理对照[J]. 临床放射学杂志, 2016, 35(8): 1190-1195.
|
[10]
|
Chen, X., Zhu, Q.Q., Li, B.X., et al. (2017) Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE Gene Fusion: Imaging Findings in 21 Patients. European Radiology, 27, 543-552.
https://doi.org/10.1007/s00330-016-4421-4
|
[11]
|
Wang, W., Ding, J.H., Li, Y., et al. (2014) Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Transloca-tion/TFE3 Gene Fusion. PLOS ONE, 9, e99990.
https://doi.org/10.1371/journal.pone.0099990
|
[12]
|
Kato, H., Kanematsu, M., Yokoi, S., et al. (2011) Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: Radiological Findings Mimicking Papillary Sub-type. Journal of Magnetic Resonance Imaging, 33, 217-220. https://doi.org/10.1002/jmri.22392
|
[13]
|
丁文双, 刘国荣, 常丽君, 等. Xp11tRCC与TFE3阳性非Xp11tRCC的临床病理特征分析[J]. 贵州医科大学学报, 2021, 46(8): 970-975.
|
[14]
|
Karashima, T., Kuno, T., Kuroda, N., et al. (2018) Bilateral Xp11.2 Translocation Renal Cell Carcinoma: A Case Report. BMC Urology, 18, Article No. 6. https://doi.org/10.1186/s12894-018-0419-3
|
[15]
|
Yang, B., Duan, H.Q., Cao, W.F., et al. (2019) Xp11 Translocation Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma with TFE3 Strong Positive Immunostaining: Morphology, Immunohistochemistry, and FISH Analysis. Modern Pathology, 32, 1521-1535. https://doi.org/10.1038/s41379-019-0283-z
|
[16]
|
王晓敏, 付刚, 任力. Xp11.2易位/TFE3基因融合相关性肾细胞癌5例临床病理及基因融合分析[J]. 诊断病理学杂志, 2019, 26(6): 338-340.
|
[17]
|
Klatte, T., Streubel, B., Wrba, F., et al. (2012) Renal Cell Carcinoma Associated with Transcription Factor E3 Expression and Xp11.2 Translocation Incidence, Characteristics, and Prognosis. American Journal of Clinical Pathology, 137, 761-768. https://doi.org/10.1309/AJCPQ6LLFMC4OXGC
|
[18]
|
Williamson, S.R., Gill, A.J., Argani, P., et al. (2020) Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Uro-genital Cancers III: Molecular Pathology of Kidney Cancer. American Journal of Surgical Pathology, 44, E47-E65. https://doi.org/10.1097/PAS.0000000000001476
|
[19]
|
Malouf, G.G., Monzon, F.A., Couturier, J., et al. (2013) Genomic Heterogeneity of Translocation Renal Cell Carcinoma. Clinical Cancer Research, 19, 4673-4684. https://doi.org/10.1158/1078-0432.CCR-12-3825
|
[20]
|
Ma, W.L., Liu, N., Zhuang, W.Y., et al. (2020) Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: A Retrospective Multicentre Study in China. Scientific Reports, 10, Article No. 2249. https://doi.org/10.1038/s41598-020-59162-5
|
[21]
|
Chang, K., Qu, Y.Y., Dai, B., et al. (2017) PD-L1 Expression in Xp11.2 Translocation Renal Cell Carcinoma: Indicator of Tumor Aggressiveness. Scientific Reports, 7, Article No. 2074. https://doi.org/10.1038/s41598-017-02005-7
|